What Is Neovascular Glaucoma in Diabetes
How Neovascular Glaucoma Develops in Diabetic Eyes
Neovascular glaucoma is almost always a consequence of proliferative diabetic retinopathy (PDR), the most advanced stage of diabetic eye disease. In PDR, widespread closure of retinal blood vessels leaves large areas of the retina without adequate oxygen. The oxygen-starved retina releases growth factors, primarily vascular endothelial growth factor (VEGF), that stimulate the formation of new blood vessels. These abnormal vessels grow on the surface of the retina and can also grow forward into other structures of the eye, including the iris (the colored part of the eye) and the drainage angle where fluid exits the eye. It is this forward growth of abnormal vessels that sets the stage for neovascular glaucoma.
The eye constantly produces a clear fluid called aqueous humor that nourishes the front part of the eye and maintains its shape. This fluid drains out of the eye through a structure called the trabecular meshwork, located in the drainage angle where the iris meets the cornea. When abnormal blood vessels grow into this drainage angle, they physically obstruct the outflow of fluid. At first, the vessels themselves cause partial blockage. Over time, the vessels are accompanied by a sheet of fibrous tissue that contracts and further closes the drainage angle. When the angle closes, the pressure inside the eye rises rapidly, sometimes to very high levels. This elevated pressure damages the optic nerve, the cable of nerve fibers that carries visual signals to the brain.
Neovascular glaucoma progresses through recognizable stages. The earliest stage is called rubeosis iridis, which refers to the growth of new blood vessels on the surface of the iris. At this stage, the drainage angle may still be partially open and the eye pressure may be normal or only mildly elevated. Your eye doctor can detect rubeosis iridis during a careful examination. The next stage involves the spread of these vessels into the drainage angle, causing progressive obstruction and rising eye pressure. In the final stage, the fibrous tissue accompanying the vessels contracts and permanently closes the drainage angle, creating a condition called angle-closure glaucoma that is very difficult to reverse. Early detection during the rubeosis iridis stage offers the best opportunity to intervene before the angle is permanently damaged.
When proliferative diabetic retinopathy is not treated with laser therapy, anti-VEGF injections, or both, the abnormal blood vessels continue to grow unchecked. The elevated levels of VEGF in the eye drive vessel growth not only on the retina but also on the iris and into the drainage angle. Without intervention to reduce VEGF levels and treat the ischemic retina, the progression from PDR to neovascular glaucoma is a matter of time. This is why prompt treatment of PDR is so critical. Treating PDR effectively prevents the forward migration of abnormal vessels and stops the cascade of events that leads to neovascular glaucoma.
Symptoms and Warning Signs
Neovascular glaucoma can cause sudden, severe pain in the affected eye. The pain results from the rapid rise in eye pressure, which stretches the wall of the eye and irritates the nerves inside it. The eye may become visibly red and inflamed. The redness comes from congestion of the blood vessels on the surface of the eye, caused by the high internal pressure impeding normal blood flow. Unlike common open-angle glaucoma, which is typically painless and develops silently, neovascular glaucoma announces itself with symptoms that are hard to ignore. If you have diabetes and develop sudden eye pain with redness, seek immediate evaluation from your eye doctor or go to an emergency room with eye care capabilities.
The elevated pressure in neovascular glaucoma damages the optic nerve, leading to vision loss that can progress rapidly over days to weeks if the pressure is not controlled. The vision loss may start as blurriness or haziness and can progress to severe impairment. In some cases, the hemorrhage from abnormal blood vessels inside the eye compounds the problem by blocking light from reaching the retina. The combination of high eye pressure, optic nerve damage, and potential bleeding makes neovascular glaucoma one of the most vision-threatening complications of diabetes. Early recognition and treatment are essential to preserve whatever vision remains.
Before the pressure rises to severely elevated levels, some people with developing neovascular glaucoma notice halos around lights, particularly at night. The cornea becomes edematous (swollen) when eye pressure is high, which causes light to scatter as it enters the eye. This scattering produces rainbow-colored halos around point light sources. Your vision may also appear foggy or hazy, as though you are looking through a steamy window. These symptoms may come and go initially if the pressure fluctuates. Persistent halos or foggy vision, especially in someone with known diabetic retinopathy, should prompt a visit to your eye doctor for a pressure check.
Before you experience any symptoms, your eye doctor can detect early warning signs of neovascular glaucoma during a routine exam. New blood vessels on the surface of the iris (rubeosis iridis) are the hallmark early finding. Your eye doctor checks the iris carefully during slit-lamp examination, looking for tiny, abnormal vessels that were not present at previous visits. They also examine the drainage angle using a special mirrored lens in a procedure called gonioscopy. Gonioscopy reveals whether abnormal vessels or fibrous tissue have begun to invade the drainage angle. Elevated eye pressure at a routine visit can also be an early indicator. Detecting these signs early, before symptoms develop, allows treatment to begin at a stage when it is most effective.
How Neovascular Glaucoma Is Treated
Anti-VEGF injections are typically the first step in treating neovascular glaucoma. These medications block the growth factor that is driving the abnormal blood vessel formation. When injected into the eye, anti-VEGF agents can cause the new vessels on the iris and in the drainage angle to regress rapidly, often within days. This regression can help lower the eye pressure by reducing the physical obstruction of the drainage pathway. Anti-VEGF therapy provides a crucial window of opportunity for additional treatments, such as laser therapy, to be applied. It is considered an essential component of the initial management of neovascular glaucoma and is especially valuable in reducing bleeding and inflammation before further procedures.
Panretinal photocoagulation (PRP) treats the underlying cause of neovascular glaucoma by addressing the ischemic retina. During PRP, the eye doctor applies hundreds of small laser burns to the peripheral retina, which reduces the retina's oxygen demand and decreases the production of VEGF. With lower VEGF levels, the stimulus for abnormal blood vessel growth diminishes, and existing abnormal vessels may shrink or stabilize. PRP is critical for long-term control because anti-VEGF injections provide temporary VEGF suppression, while PRP provides a more durable reduction. In many cases, anti-VEGF injections and PRP are used together, with the injections providing immediate relief and the laser providing lasting benefit.
Eye drops that lower intraocular pressure are used alongside the treatments targeting the abnormal blood vessels. These drops work through various mechanisms: some reduce the amount of fluid the eye produces, while others increase the rate at which fluid drains out. In neovascular glaucoma, pressure-lowering drops are an important adjunct, but they are rarely sufficient on their own to control the pressure when the drainage angle is significantly compromised. Your eye doctor will select the combination of drops best suited to your situation and monitor your pressure closely to ensure adequate control. In some cases, oral medications that reduce fluid production in the eye may also be prescribed temporarily when the pressure is very high.
If anti-VEGF injections, laser treatment, and pressure-lowering drops cannot adequately control the eye pressure, surgical intervention may be necessary. Glaucoma drainage implant surgery involves placing a small device that creates an alternative pathway for fluid to exit the eye, bypassing the blocked drainage angle. This can be an effective option for controlling pressure in eyes where the angle is permanently closed by fibrous tissue. In very advanced cases where the eye has lost useful vision and is painful, procedures that reduce the eye's ability to produce fluid, such as cyclophotocoagulation (laser treatment to the ciliary body), may be used to relieve pain and reduce pressure. Your eye doctor will discuss the appropriate surgical option based on the severity of your condition and the amount of remaining vision.
How Neovascular Glaucoma Differs From Regular Glaucoma
The most common form of glaucoma, open-angle glaucoma, develops when the drainage system of the eye becomes less efficient over many years for reasons that are not fully understood. The pressure rises gradually, and the optic nerve damage occurs slowly. Neovascular glaucoma has a specific, identifiable cause: the growth of abnormal blood vessels that physically block the drainage pathway. This makes it a secondary glaucoma, meaning it develops as a consequence of another condition, in this case proliferative diabetic retinopathy. Understanding this causal relationship is important because treating the underlying retinopathy is as critical as lowering the eye pressure.
Open-angle glaucoma typically develops over years and may not cause noticeable symptoms until a significant amount of peripheral vision has been lost. Neovascular glaucoma can develop over weeks to months and cause rapid, severe vision loss along with pain and redness. The eye pressure in neovascular glaucoma can reach much higher levels than in typical open-angle glaucoma, causing more rapid and severe damage to the optic nerve. This faster onset and greater severity make neovascular glaucoma a more urgent condition that requires prompt, aggressive treatment.
While open-angle glaucoma is primarily managed with pressure-lowering drops, laser, or surgery directed at the drainage system, neovascular glaucoma requires a multi-pronged approach that addresses both the elevated pressure and the underlying vascular disease. Anti-VEGF injections and PRP laser treatment are essential components of treating neovascular glaucoma that are not part of standard open-angle glaucoma management. This dual focus, controlling pressure and treating the root cause, distinguishes neovascular glaucoma treatment from the management of other forms of glaucoma.
The long-term outlook for neovascular glaucoma depends heavily on when it is detected and how quickly treatment begins. When caught at the rubeosis iridis stage, before the drainage angle is permanently closed, the prognosis is more favorable. Anti-VEGF injections can cause the new vessels to regress, and PRP can prevent them from returning. Once the angle is permanently scarred shut, the pressure is harder to control and the optic nerve may have already sustained significant damage. Even with surgical drainage devices, advanced neovascular glaucoma can be difficult to manage long term. This reinforces the importance of regular monitoring and early intervention for anyone with proliferative diabetic retinopathy.
Preventing Neovascular Glaucoma
The most effective prevention strategy is to treat diabetic retinopathy before it reaches the proliferative stage. Regular dilated eye exams detect retinopathy at its earliest stages, when interventions like improved blood sugar control and monitoring can slow progression. If retinopathy advances to the severe nonproliferative or proliferative stage, prompt treatment with PRP and anti-VEGF injections reduces the VEGF levels that drive abnormal vessel formation. When PDR is treated effectively, the chain of events leading to neovascular glaucoma is interrupted. Patients diagnosed with high-risk PDR should receive treatment without delay.
Keeping blood sugar within your target range slows the progression of diabetic retinopathy through all its stages. Consistent blood sugar management reduces the ongoing damage to retinal blood vessels and lowers the overall VEGF burden inside the eye. Blood pressure control provides additional protection by reducing the mechanical stress on already compromised blood vessels. Together, good blood sugar and blood pressure management form the foundation of diabetic eye disease prevention, including the prevention of neovascular glaucoma.
Annual dilated eye exams are the minimum standard for anyone with diabetes. More frequent exams are recommended if retinopathy has been detected. Your eye doctor monitors the iris and drainage angle in addition to the retina during these visits, watching for the early signs of neovascular changes. If your eye doctor identifies rubeosis iridis or early angle involvement, treatment can begin immediately, before the condition progresses to full-blown neovascular glaucoma with elevated pressure and optic nerve damage. Consistent attendance at your scheduled eye appointments is one of the most effective things you can do to prevent this serious complication.
Frequently Asked Questions About Neovascular Glaucoma and Diabetes
New blood vessels on the iris, called rubeosis iridis, are an early warning sign of neovascular glaucoma. These vessels grow in response to high levels of VEGF in the eye, typically from advanced diabetic retinopathy where large areas of the retina are oxygen-starved. If these vessels spread into the drainage angle of the eye, they can block fluid outflow and cause the eye pressure to rise dangerously. Detecting them early is actually good news because treatment with anti-VEGF injections and laser can stop their progression before they cause pressure problems.
Regular open-angle glaucoma develops slowly over years due to gradual inefficiency of the drainage system, usually without pain or sudden symptoms. Neovascular glaucoma develops more rapidly and is caused by abnormal blood vessels that physically block the drainage angle. It can cause sudden pain, redness, and rapid vision loss. Treatment requires not only lowering the eye pressure but also treating the underlying retinal disease that is driving the abnormal vessel growth. Neovascular glaucoma is a more urgent condition that demands prompt, aggressive intervention.
Yes. When abnormal blood vessels block the drainage angle and eye pressure rises sharply, it causes pain, redness, and often blurry or hazy vision. The pain can be quite severe due to the stretching of the eye wall from the high internal pressure. The redness results from congested blood vessels on the surface of the eye. These symptoms represent a medical emergency that requires immediate evaluation and treatment to protect the optic nerve from further damage.
Neovascular glaucoma is treatable, especially when detected early. Anti-VEGF injections can rapidly reduce the abnormal blood vessels, and panretinal laser treatment addresses the underlying retinal ischemia. Pressure-lowering medications and, in some cases, surgical drainage devices help control eye pressure. When treatment begins at the rubeosis iridis stage, before the angle is permanently scarred closed, the outcomes are significantly better. However, if neovascular glaucoma is diagnosed at an advanced stage with extensive angle closure and optic nerve damage, some vision loss may be irreversible. This is why early detection through regular exams is so important.
Your eye doctor can reduce your risk of developing neovascular glaucoma by treating your proliferative retinopathy aggressively. Panretinal photocoagulation (PRP) reduces the retina's oxygen demand and lowers VEGF production, which removes the stimulus for abnormal vessel growth. Anti-VEGF injections provide immediate VEGF suppression while the laser takes effect. Your eye doctor will also monitor your iris and drainage angle at each visit to watch for the earliest signs of neovascular changes. Maintaining good blood sugar and blood pressure control provides additional protection. With consistent treatment and monitoring, the progression from PDR to neovascular glaucoma can be prevented in most cases.
Neovascular glaucoma can potentially affect both eyes if both have advanced diabetic retinopathy with significant retinal ischemia. However, it does not necessarily develop in both eyes at the same time. If your eye doctor detects neovascular glaucoma in one eye, they will closely monitor the other eye for similar changes. Treating any existing retinopathy in the other eye with laser therapy and maintaining good blood sugar control can help reduce the risk. The development of neovascular glaucoma in one eye should be taken as a strong signal that aggressive management of both eyes is needed.